Plus, FX006, odanacatib and other rheumatology drug news, safety updates
Search results for: osteoporosis
Choosing Wisely: Recommendations from Medical Specialties Beyond Rheumatology
Practice gems that may help rheumatologists avoid performing costly patient tests, procedures of limited use
Persistent Symptomatic Hypocalcemia Due to Denosumab: A Case Review
Patients with osteoporosis and impaired renal function are at risk
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss
Plus, rheumatology drug news from EULAR 2014
Orexin’s Yin/Yang Functions Regulate Bone Remodeling
Working both to support bone formation and suppress it, a new study reveals orexin neuropeptides are essential regulators of skeletal homeostasis
Rheumatologists on the Move
Awards, appointments and announcements in the world of rheumatology
Rheumatologist Marc C. Hochberg, MD, MPH, Advances Epidemiology Through Collaborative Ties
Accomplished physician noted for research in gout, osteoarthritis etiology; characterizing therapeutic responsiveness in disease states; inspiring teamwork among rheumatologists
U.S. Bone and Joint Initiative Summit Examines Quality of Patient-Centered Musculoskeletal Care
Physicians discuss definition, implementation of best clinical practices for patient care at multidisciplinary meeting last November
Coding Corner Question: May
Test your knowledge of medical terms associated with ICD-10 coding
Rheumatology Drug Updates, Trials, Safety Data
Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 58
- Next Page »